The ultimate objective of our study was the identification of key mechanisms by which Nlgn2 and MDGAs contribute to relevant phenotypes of psychiatric disorders they have been linked to, such as anxiety, autism and schizophrenia7,21,34–43, and to determine how such mechanisms can be targeted to ameliorate pathophysiological behaviors. This evidence concerns the gene NLGN2 and psychiatric disorder.